Profile of the Philippine pharmaceutical sector / (Record no. 1535)

MARC details
000 -LEADER
fixed length control field 02473nam a22002897a 4500
001 - CONTROL NUMBER
control field D0001E000093
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20201012101942.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201012b ||||| |||| 00| 0 eng d
040 ## - CATALOGING SOURCE
Description conventions rda
245 00 - TITLE STATEMENT
Title Profile of the Philippine pharmaceutical sector /
Statement of responsibility, etc. Celia M. Reyes [and four others]
300 ## - PHYSICAL DESCRIPTION
Extent 72 pages :
Other physical details tables, graphs.
336 ## - CONTENT TYPE
Source rdacontent
Content type text
337 ## - MEDIA TYPE
Source rdamedia
Media type unmediated
338 ## - CARRIER TYPE
Source rdacarier
Carrier type term volume
490 ## - SERIES STATEMENT
Series statement DISCUSSION PAPER SERIES
Volume/sequential designation NO. 2011-11
520 3# - SUMMARY, ETC.
Summary, etc. The Philippines is one of the biggest pharmaceutical markets in the ASEAN region, next only to<br/>Indonesia and Thailand.1<br/> It is a lifeline to thousands of Filipino workers and a significant<br/>contributor in terms of value of output. This industry is one of the fastest growing industries in<br/>the country. Meanwhile, its output, drugs and medicines, account for 46 percent of the total<br/>medical out-of-pocket expenses of Philippine households. For poorer people, this percentage<br/>goes up to 55 percent.2<br/> Making essential drugs and medicines more affordable especially to the<br/>poor and underserved is one of the Millennium Development Goals (MDGs). It is therefore<br/>essential to examine the profile of the pharmaceutical industry in the country to better understand<br/>the supply chain of drugs and medicines for policy formulation purposes. Using administrative<br/>data from agencies that have regulative powers over the industry, a profile of the Philippine<br/>pharmaceutical industry was developed. As of December 2009, the Food and Drug<br/>Administration’s records show that there are 284 drug manufacturers, 438 drug traders, 634 drug<br/>importers, 4,719 drug distributors of which 3,956 are wholesalers, and 32,538 retail outlets.<br/>Manufacturing is dominated by multi-national brand originator giants and numerous local<br/>generics/branded generics producers. Meanwhile, trading is done by few large companies and<br/>thousands of small retail outlets. The industry players are diverse and formulating policies<br/>therefore must take into consideration how each player may be affected by policy issuances.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Industry
Geographic subdivision Philippines
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Pharmaceutical Industry -- Philippines
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Reyes, Celia M.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lavado, Rouselle F.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tabuga, Aubrey D.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Asis, Ronina D.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Datu, Maria Blesila G.
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://dirp4.pids.gov.ph/ris/dps/pidsdps1111.pdf">https://dirp4.pids.gov.ph/ris/dps/pidsdps1111.pdf</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Technical Report
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
        DOH Central Library DOH Central Library Electronic Resource Section 10/12/2020   E000093 D0001E000093 10/12/2020 10/12/2020 Technical Report